127
Views
22
CrossRef citations to date
0
Altmetric
Original Research

A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway

, , , ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 10061-10077 | Published online: 24 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yuan Ji-hong, Ma Yu, Yuan Ling-hong, Gong Jing-jing, Xu Ling-li, Wang Lv & Jin Yong-mei. (2023) Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression. Pharmaceutical Biology 61:1, pages 288-297.
Read now
Beilei Ma, Yicheng Mao, Lingling Chang, Tao Dai, Xiaoming Xin, Fenfen Ma, Zhijun Wang, Zhuqing Shen, Qibing Mei & Yizhun Zhu. (2022) S-Propargyl-cysteine prevents concanavalin A-induced immunological liver injury in mice. Pharmaceutical Biology 60:1, pages 1169-1176.
Read now
Yue Yu, Qinyan Yang, Zhou Wang, Qian Ding, Meng Li, Yudong Fang, Qida He & Yi Zhun Zhu. (2021) The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine. Journal of Inflammation Research 14, pages 5863-5875.
Read now
Yue Yu, Zhou Wang, Qinyan Yang, Qian Ding, Ran Wang, Zhaoyi Li, Yudong Fang, Junyi Liao, Wei Qi, Keyuan Chen, Meng Li & Yi Zhun Zhu. (2021) A novel dendritic mesoporous silica based sustained hydrogen sulfide donor for the alleviation of adjuvant-induced inflammation in rats. Drug Delivery 28:1, pages 1031-1042.
Read now

Articles from other publishers (18)

Katarzyna Kaziród, Małgorzata Myszka, Józef Dulak & Agnieszka Łoboda. (2022) Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. Cellular and Molecular Life Sciences 79:12.
Crossref
Zsófia Németh, Ildikó Csóka, Reza Semnani Jazani, Bence Sipos, Henrik Haspel, Gábor Kozma, Zoltán Kónya & Dorina Gabriella Dobó. (2022) Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives. Pharmaceutics 14:9, pages 1798.
Crossref
Payal Kesharwani, Kajal Kumari, Ritika Gururani, Smita Jain & Swapnil Sharma. (2022) Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System. Current Drug Metabolism 23:9, pages 678-692.
Crossref
Ling Li, Ziying He, Yue Zhu, Qiyan Shen, Shengju Yang & Shuanglin Cao. (2022) Hydrogen Sulfide Suppresses Skin Fibroblast Proliferation via Oxidative Stress Alleviation and Necroptosis Inhibition. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Domenico Marson, Suzana Aulic, Alice Fermeglia, Erik Laurini & Sabrina Pricl. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 341 369 .
Margaret G. Lamb, Hemalatha G. Rangarajan, Brian P. Tullius & Dean A. Lee. (2021) Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future. Stem Cell Research & Therapy 12:1.
Crossref
Swathy S Chirindoth & Ivan Cancarevic. (2021) Role of Hydrogen Sulfide in the Treatment of Fibrosis. Cureus.
Crossref
Jing Dai, Xu Teng, Sheng Jin & Yuming Wu. (2021) The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS-CoV-2 and Its Potential Cell Surface Receptors. Oxidative Medicine and Cellular Longevity 2021, pages 1-11.
Crossref
Fabiana Passaro, Carlo Gabriele Tocchetti, Gaia Spinetti, Francesca Paudice, Luigi Ambrosone, Ciro Costagliola, Francesco Cacciatore, Pasquale Abete & Gianluca Testa. (2021) Targeting fibrosis in the failing heart with nanoparticles. Advanced Drug Delivery Reviews 174, pages 461-481.
Crossref
Lukas Roubenne, Roger Marthan, Bruno Le Grand & Christelle Guibert. (2021) Hydrogen Sulfide Metabolism and Pulmonary Hypertension. Cells 10:6, pages 1477.
Crossref
Lara Testai, Vincenzo Brancaleone, Lorenzo Flori, Rosangela Montanaro & Vincenzo Calderone. (2021) Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis. Antioxidants 10:6, pages 910.
Crossref
Yue Yu, Zhou Wang, Qian Ding, Xiangbin Yu, Qinyan Yang, Ran Wang, Yudong Fang, Wei Qi, Junyi Liao, Wei Hu & Yizhun Zhu. (2021) The Preparation of a Novel Poly(Lactic Acid)-Based Sustained H2S Releasing Microsphere for Rheumatoid Arthritis Alleviation. Pharmaceutics 13:5, pages 742.
Crossref
Somayeh Saadat, Mahdi Noureddini, Maryam Mahjoubin-Tehran, Sina Nazemi, Layla Shojaie, Michael Aschner, Behnaz Maleki, Mohammad Abbasi-kolli, Hasan Rajabi Moghadam, Behrang Alani & Hamed Mirzaei. (2021) Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players. Frontiers in Cardiovascular Medicine 7.
Crossref
海燕 席. (2021) Research Progress on Pharmacological Effects of S-Propargyl-Cysteine, the Endogenous Hydrogen Sulfide Donor. Pharmacy Information 10:05, pages 274-282.
Crossref
Jaimy Saif, Shakil Ahmad, Homira Rezai, Karina Litvinova, Anna Sparatore, Faisal A. Alzahrani, Keqing Wang & Asif Ahmed. (2021) Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model. Redox Biology 38, pages 101814.
Crossref
Qian Ding & Yi-Zhun Zhu. 2021. Advances in Hydrogen Sulfide Biology. Advances in Hydrogen Sulfide Biology 181 203 .
Francesca Gorini, Elisa Bustaffa, Kyriazoula Chatzianagnostou, Fabrizio Bianchi & Cristina Vassalle. (2020) Hydrogen sulfide and cardiovascular disease: Doubts, clues, and interpretation difficulties from studies in geothermal areas. Science of The Total Environment 743, pages 140818.
Crossref
Lara Testai, Valentina Citi, Alma Martelli, Simone Brogi & Vincenzo Calderone. (2020) Role of hydrogen sulfide in cardiovascular ageing. Pharmacological Research 160, pages 105125.
Crossref